Log in to save to my catalogue

The BET inhibitor apabetalone decreases neuroendothelial proinflammatory activation in vitro and in...

The BET inhibitor apabetalone decreases neuroendothelial proinflammatory activation in vitro and in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6ed3c2d040cb42c6909638ca4b5fbb62

The BET inhibitor apabetalone decreases neuroendothelial proinflammatory activation in vitro and in a mouse model of systemic inflammation

About this item

Full title

The BET inhibitor apabetalone decreases neuroendothelial proinflammatory activation in vitro and in a mouse model of systemic inflammation

Publisher

Germany: De Gruyter

Journal title

Translational neuroscience, 2023-01, Vol.14 (1), p.20220332-20220332

Language

English

Formats

Publication information

Publisher

Germany: De Gruyter

More information

Scope and Contents

Contents

Brain vascular inflammation is characterized by endothelial activation and immune cell recruitment to the blood vessel wall, potentially causing a breach in the blood – brain barrier, brain parenchyma inflammation, and a decline of cognitive function. The clinical-stage small molecule, apabetalone, reduces circulating vascular endothelial inflammat...

Alternative Titles

Full title

The BET inhibitor apabetalone decreases neuroendothelial proinflammatory activation in vitro and in a mouse model of systemic inflammation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6ed3c2d040cb42c6909638ca4b5fbb62

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6ed3c2d040cb42c6909638ca4b5fbb62

Other Identifiers

ISSN

2081-3856,2081-6936

E-ISSN

2081-6936

DOI

10.1515/tnsci-2022-0332

How to access this item